Navigation Links
H. D. Smith Completes Full Ownership Acquisition Of Triplefin, Solidifying End-To-End Value Chain For Pharmaceutical And Patient Support Services
Date:9/30/2013

SPRINGFIELD, Ill., Sept. 30, 2013 /PRNewswire/ -- H. D. Smith, among the nation's largest pharmaceutical wholesalers and pharmaceutical services providers, today announced full ownership acquisition of Triplefin, a reimbursement, patient assistance and pharmaceutical brand-support services Company, headquartered in Cincinnati, Ohio. H. D. Smith secured majority representation on Triplefin's board of directors in January, 2013 and majority stock ownership interest in May, 2013. H.D. Smith has now acquired the remaining 49% of shares in Triplefin giving the Company full ownership. Triplefin will operate as a wholly owned subsidiary of H. D. Smith within the H. D. Smith Specialty Solutions Operating Unit. Financial terms of the full ownership acquisition remain confidential.

(Logo: http://photos.prnewswire.com/prnh/20121015/NY93014LOGO)

"H. D. Smith is committed to providing end-to-end value throughout the healthcare chain to our customers and the patients they serve – and the Triplefin mission to remove barriers, connect patients and grow brands fits perfectly with the H. D. Smith Specialty Solutions focus on the patient journey," said Dale Smith, chairman and executive officer, H. D. Smith. "Our interest in Triplefin began a year ago, sparked by the company's specialized offerings across patient support programs, distribution/fulfillment, marketing, pharmacy services, technology and specialty product education functions. Together, our organizations have already integrated many of our functions, and established an end-to-end service value chain touching all aspects of prescription medicine distribution and support – and we look forward to continuing to grow together." 

Together, the combined organization will continue to provide support services to traditional brand and specialty product manufacturers and pharmacy partners, including critical distribution and fulfillment functions, patient assistance and reimbursement programs, third-party logistics, pharmaceutical marketing, and product education.

"Triplefin shares the H. D. Smith Specialty Solutions commitment to supporting patients from the moment they begin receiving care, to the completion of their treatment – and together, we have the exciting opportunity to revolutionize the industry and help protect patient wellness," said Joseph Conda, president of H. D. Smith Specialty Solutions. "We remain impressed and inspired by the organization that Greg LaLonde and Rick Randall have built over the past 10 years, and we are enthusiastic about driving their mission forward – reshaping the patient journey through end-to-end solutions. That vision, and the best-in-class Triplefin services that bring it to life, are a critical part of our H. D. Smith strategic vision: to be the leader in controlling healthcare costs while maximizing patient outcomes."

About H. D. Smith

Headquartered in Springfield, Illinois, H. D. Smith is among the largest national wholesale distributors, with services and solutions for manufacturers and healthcare providers in providing products, services and care for patients nationwide. H. D. Smith has two operating units: Wholesale Distribution and Specialty Solutions. H. D. Smith Wholesale Distribution provides a complete line of prescription products, over-the-counter, health and beauty aids, home healthcare products, durable medical equipment, seasonal merchandise and a wide array of marketing programs to retail pharmacies, regional chains and health systems. Distribution facilities are located in California, Florida, Kentucky, Illinois, New Hampshire, New Jersey and Texas and serve major markets throughout the United States. In addition, H. D. Smith operates a home healthcare (HHC) distribution center in Texas; SmartSource, a generic distributor; and Valley Wholesale Drug, a regional healthcare distributor located in northern California. H. D. Smith Specialty Solutions provides end-to-end services and support programs for traditional and specialty pharmaceutical providers and patients, including specialty distribution, third-party logistics, clinical trials drug procurement, physician education, patient access, patient on-boarding and treatment, reimbursement, adherence and compliance support.    

Additional information about H. D. Smith can be found at hdsmith.com.

About Triplefin

Triplefin, a wholly owned subsidiary of H. D. Smith, is headquartered in Cincinnati, Ohio and has been recognized as a premier provider of pharmaceutical marketing support solutions. For more than 10 years, Triplefin has helped pharmaceutical brand managers remove barriers to brand access and adherence and put prescription brands into patients' hands…and keep them there throughout treatment.

Today, more than 45 pharmaceutical manufacturing companies (including 15 of the top 20), representing more than 150 brands across multiple therapeutic categories, have connected with Triplefin and experienced success with Triplefin's solutions. Our mission is to connect patients, providers, pharmacies and payers to improve outcomes and to remove brand challenges with access, acquisition and adherence.

Contact:
Mark Marmur
Makovsky + Company, Inc.
212-508-9670
mmarmur@makovsky.com

Carolyn Webb
H. D. Smith
217-747-8125
carolyn.webb@hdsmith.com


'/>"/>
SOURCE H. D. Smith
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Healthpoint Biotherapeutics To Assume Smith & Nephew Name
2. Clinical Trial Results, Litigation Outcomes and Marketing Authorizations - Research Report on Pfizer, GlaxoSmithKline, Sanofi, AstraZeneca, and Neurocrine
3. GlaxoSmithKline, Community Care of North Carolina harness "small data" to improve patient care and reduce health care costs
4. SHAREHOLDER ALERT: Law Office of Brodsky & Smith, LLC Announces Investigation of Astex Pharmaceuticals, Inc.
5. Upsher-Smith Announces Commercial Availability Of Morphine Sulfate ER Capsules
6. Upsher-Smith Teams Up With Epilepsy Foundation Of Minnesota For 2013 Stroll For Epilepsy
7. GlaxoSmithKline CFO Interviewed on Q2 Results
8. Upsher-Smith Announces Patient Enrollment In Open-label Safety Study Of USL261 (Intranasal Midazolam) For Rescue Treatment Of Seizure Clusters In Epilepsy
9. H. D. Smith Completes Acquisition Of Pharmaceutical Support Services Company Triplefin
10. Upsher-Smith Is Honored With Prestigious Industry Award For Leadership And Innovation
11. Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/11/2017)... , May 11, 2017  Thornhill Research Inc. ... been awarded an $8,049,024 USD five-year, firm-fixed-priced, indefinite-quantity/indefinite-delivery ... the Canadian Commercial Corporation (CCC) ( Ottawa, ... Systems to administer general anesthesia to patients requiring ... "The US Marine Corps have been a ...
(Date:5/10/2017)... 2017 CSSi, the global leader in patient ... industry, is proud to announce the launch of its ... features both enriched content and a customized layout that ... company,s already well-established position as the top global patient ... many months of hard work, we are delighted to ...
(Date:5/8/2017)... 8, 2017 MACRA replaces the outdated ... for service reimbursement. Black Book Research crowdsource-surveyed 8,845 physician ... 1.       The Market for MIPS Compliance Technology is Booming ... practices with 3 or more clinicians seek to buy ... "Given the magnitude of the changes, the hunt is ...
Breaking Medicine Technology:
(Date:5/26/2017)... ... ... “Just What Happened in the Garden of Eden”: retells the stories of three Bible figures ... of published author, Penelope Colt, mother, trader, horse farmer, artist and a former GM journeyman. ... three. At six, they moved to Dayton, Ohio, where Penny graduated high school. ...
(Date:5/24/2017)... , ... May 24, 2017 , ... ... background. Understanind and choosing the most appropriate instruments for research and understanding the ... research finding. This webinar will focus on innovations in stereo microscopy for brightfield ...
(Date:5/24/2017)... ... May 24, 2017 , ... ... Bayside, NY, who have now spent 10 years as clinical instructors for the ... (NYU) College of Dentistry. Through the program, private practitioners receive cutting-edge clinical training ...
(Date:5/24/2017)... ... 24, 2017 , ... Myers Jackson is well known for auctioning homes that ... homes anywhere on the planet. The luxury home market is alive and well and ... A quick search of “11 Spyglass Hill Auction will enlighten you on the dynamics ...
(Date:5/24/2017)... ... May 24, 2017 , ... Accordant Technology, a ... portfolio. ExtraHop delivers an analytics-first approach, layered with machine learning, that provides real-time ... datacenter to the cloud to the edge. Through the new partnership, customers get ...
Breaking Medicine News(10 mins):